Mice lacking macrophage 12/15-lipoxygenase are resistant to experimental hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 11, 2012, Pages

  Kriska, Tamas ^a   Cepura, Cody ^a   Magier, Devora ^a   Siangjong, Lawan ^a   Gauthier, Kathryn M ^a   Campbell, William B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arachidonic acid; Eicosanoids

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ACETYLCHOLINE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; CLODRONIC ACID; DEOXYCORTICOSTERONE ACETATE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NORDIHYDROGUAIARETIC ACID;

ABDOMINAL AORTA; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HYPERTENSION; IMMUNODETECTION; INTESTINE; LUNG; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN; SPLEEN; SYSTOLIC BLOOD PRESSURE; WILD TYPE;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; HYPERTENSION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; VASODILATION;

EID: 84861764903     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01120.2011     Document Type: Article

References (58)

1. Anning PB, Coles B, Bermudez-Fajardo A, Martin PEM, Levison BS, Hazen SL, Funk CD, Kuhn H, O'Donnell VB. Elevatged endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice. Am J Pathol 166: 653-662, 2005.
2. Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadel JA. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest 103: 1431-1436, 1999.
3. Brash AR. Lipoxygenases: occurrences, function, catalysis, and acquisition of substrate. J Biol Chem 274: 23679-23682, 1999.
4. Bryant RW, Bailey JM. Rearrangement of 15-hydroperoxy-eicosatetraenoic acid (15-HPETE) during incubations with hemoglobin: a model for platelet lipoxygenase metabolism. Prog Lipid Res 20: 279-281, 1981.
5. Campbell WB, Falck JR. Arachidonic acid metabolites as endotheliumderived hyperpolarizing factors. Hypertension 49: 590-596, 2007.
6. Campbell WB, Spitzbarth N, Gauthier KM, Pfister SL. 11,12,15-Trihydroxyeicosatrienoic acid mediates acetylcholine-induced relaxations in the rabbit aorta. Am J Physiol Heart Circ Physiol 285: H2648-H2656, 2003.
7. Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadel JA. 12/15-Lipoxygenase products induce inflamation and impair insulin signaling in 3T3-Li adipocytes. Obesity 17: 1657-1663, 2009.
8. Chauhan SD, Nilsson H, Ahluwalia A, Hobbs AJ. Release of C-type natriuretic peptide accounts for the biological activity of endotheliumderived hyperpolarizing factor. Proc Natl Acad Sci USA 100: 1426-1431, 2003.
9. Chawengsub Y, Gauthier KM, Campbell WB. Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone. Am J Physiol Heart Circ Physiol 297: H495-H507, 2009.
10. Chen XS, Kurre U, Jenkins NA, Copeland NG, Funk CD. cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem 269: 13979-13987, 1994.
11. Coffey MJ, Natarajan R, Chumley PH, Coles B, Thimmalapura PR, Nowell M, Kuhn H, Lewis MJ, Freeman BA, O'Donnell VB. Catalytic consumption of nitric oxide by 12/15-lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation. Proc Natl Acad Sci USA 98: 8006-8011, 2001.
12. Cyrus T, Pratico D, Zhao L, Witztum JL, Rader DJ, Rokach J, FitzGerald GA, Funk CD. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation 103: 2277-2282, 2001.
13. De Marzo N, Sloane DL, Dicharry S, Highland E, Sigal E. Cloning and expression of an airway epithelial 12-lipoxygenase. Am J Physiol Lung Cell Mol Physiol 262: L198-L207, 1992.
14. Endsley MPAN, Isbell MA, Wheelock CE, Hammock BD, Falck JR, Campbell WB, Nithipatikom K. Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: location, hydrolysis and 12-linoxvgenase metaholism. Int J Cancer 121: 984-991, 2007.
15. Förstermann U, Neufang B. The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. Eur J Pharmacol 103: 65-70. 1984.
16. Fox A, Koulmanda M, Mandel TE, van Rooijen N, Harrison LC. Evidence that macrophages are required for T-cell infiltration and rejection of fetal pig pancreas xenografts in nonobese diabetic mice. Transplantation 66: 1407-1416, 1998.
17. Funk CD. The molecular biology of mammalian lipoxygenases and the quest for eicosanoid function using lipoxygenase-deficient mice. Biochim Biophys Acta 304: 65-84, 1996.
18. Funk CD, Cyrus T. 12/15-Lipoxygenase, oxidative modification of LDL and atherogenesis. Trends Cardiovasc Med 11: 116-124, 2001.
19. Furchgott RF, Zawadzki JW. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
20. Gauthier KM, Chawengsub Y, Goldman DM, Conrow RE, Anjaiah S, Falck JR, Campbell WB. 11(R),12(S),15(S)-trihydroxyeicosatrienoic acid: an endothelium-derived 15-lipoxygenase metabolite that relaxes rabbit aorta. Am J Physiol Heart Circ Physiol 294: H1467-H1472, 2008.
21. Gauthier KM, Goldman DH, Aggarwal NT, Chawengsub Y, Falck JR, Campbell WB. Role of arachidonic acid lipoxygenase metabolites in acetylcholine relaxations of mouse arteries. Am J Physiol Heart Circ Physiol 300: H725-H735, 2011.
22. + currents mediate arachidonic acid-induced relaxations of rabbit aorta. Hypertension 43: 413-419, 2004.
23. George J, Afek A, Shaish A, Levkovitz H, Bloom N, Cyrus T, Zhao L, Funk CD, Sigal E, Harats D. 12/15-lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 104: 1646-1650. 2001.
24. Gonzalez-Nunez D, Claria J, Rivera F, Poch E. Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension 37: 334-338, 2001.
25. Gordon S. The role of the macrophage in immune regulation. Res Immunol 149: 685-688, 1998.
26. Gronert K, Maheshwari N, Khan MT, Hassan IR, Dunn MJ, Schwartzman ML. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 280: 15267-15278. 2005.
27. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Wey CM. Inflamation, immunity, and hypertension. Hypertension 57: 132-140. 2011.
28. Hercule HC, Schunck WH, Gross V, Seringer J, Leung FP, Weldon SM, Goncalves A, Huang Y, Luft FC, Gollasch M. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice. Arterioscler Thromb Vasc Biol 29: 54-60, 2009.
29. Huo Y, Zhao L, Hyman MC, Shashkin P, Harry BL, Burcin T, Forlow SB, Stark MA, Smith DF, Clarke S, Srinivasan S, Hedrick CC, Pratico D, Witztum JL, Nadel JA, Funk CD, Ley K. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 110: 2024-2031, 2004.
30. Kawajiri H, Hsi LC, Kamitani H, Ikawa H, Geller M, Ward T, Eling TE, Glasgow WC. Arachidonic and linoleic acid metabolism in mouse intestinal tissue: evidence for novel lipoxygenase activity. Arch Biochem Biophys 398: 51-60, 2002.
31. Kayama Y, Minamino T, Toko H, Sakamoto M, Shimizu I, Takahashi H, Okada S, Tateno K, Moriya J, Yokoyama M, Nojima A, Yoshimura M, Egashira K, Aburatani H, Komuro I. Cardiac 12/15 lipoxygenase-induced inflamation is involved in heart failure. J Exp Med 206: 1565-1574, 2009.
32. Kobayashi M, Inoue K, Warabi E, Minami T, Kodama T. A simple method for isolating mouse aortic endothelial cells. J Atheroscler Thromb 12: 138-142, 2005.
33. Kuhn H, Chan L. The role of 15-lipoxygenase in atherogenesis: a proand antiatherogenic actions. Curr Opin Lipidol 8: 111-117, 1997.
34. Kuhn H, Thiele BJ. Arachidonate 15-lipoxygenase. J Lipid Mediat Cell Signal 12: 157-170, 1995.
35. Kuhn H, Thiele BJ, Ostareck-Lederer A, Stender H, Suzuki H, Yoshimoto T, Yamamoto S. Bacterial expression, purification and partial characterization of recombinant rabbit reticulocyte 15-lipoxygenase. Biochim Biophys Acta 1168: 73-78, 1993.
36. Lee YW, Kuhn H, Kaiser S, Kenning G, Daugherty A, Toborek M. Interleukin-4 induces transcription of the 15-lipoxygenase-1 gene in human endothelial cells. J Lipid Res 42: 783-791, 2001.
37. Li SL, Dwarakanath RS, Cai Q, Lanting L, Natarajan R. Effect of silencing leukocyte-type 12/15-lipoxygenase using short interfering RNAs. J Lipid Res 46: 220-229, 2005.
38. Li X, Hong S, Li PL, Zhang Y. Docosahexanoic acid-induced coronary arterial dilation: action of 17S-hydroxy docasahexanoic acid on K channel activity. J Pharmacol Exp Ther 336: 891-899, 2011.
39. Limor R, Weisinger G, Gilad S, Knoll E, Sharon O, Jaffe A, Kohen F, Berger E, Lifschizt-Mercer B, Stern N. A novel form of platelet-type 12-lipoxygenase mRNA in human vascular smooth muscle cells. Hypertension 38: 864-871, 2001.
40. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kandaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106: 1521-1530, 2000.
41. Ostareck DH, Ostareck-Lederer A, Wihn M, Thiele BJ, Mann M, Hentze MW. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end. Cell 89: 597-606, 1997.
42. Pfister SL, Spitzbarth N, Nithipatikom K, Edgemond WS, Falck JR, Campbell WB. Identification of 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J Biol Chem 273: 30879-30887, 1998.
43. Scotland RS, Madhani M, Chauhan SD, Moncada S, Andresen J, Nilsson H, Hobbs AJ, Ahulwalia A. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 11 1: 796-803, 2005.
44. Serhan CN, Hamberg M, Samuelson B. Lipoxins: a new series of biologically active compounds. In: Prostaglandins, Leukotriens and Lipoxins, edited by Bailey JM. New York: Plenum, 1985, p. 3-16.
45. Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, Matusik RJ. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res 63: 2256-2267, 2003.
46. Shappell SB, Taylor AA, Hughes H, Mitchell JR, Anderson DC, Smith CW. Comparison of antioxidant and nonantioxidant lipoxygenase inhibitors on neutrophil function. Implications for pathogenesis of myocardial reperfusion injury. J Phanmacol Exp Ther 252: 531-538, 1990.
47. Stern N, Kisch ES, Knoll E. Platelet lipoxygenasein spontaneously hypertensive rats. Hypertension 27: 1149-1152, 1996.
48. Sun D, Funk CD. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. J Biol Chem 271: 24055-24062, 1996.
49. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand A 84: 523-528, 1976.
50. Tang X, Holmes BB, Nithipatikom K, Hillard CJ, Kuhn H, Campbell WB. Reticulocyte 15-lipoxygenase-1 is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta. Arterioscler Thromb Vasc Biol 26: 78-84. 2006.
51. Taylor AM, Hanchett R, Natarajan R, Hedrick CC, Forrest S, Nadler J, McNamara CA. The effects of leukocyte-type 12/15-lipoxygenase on Id3-mediated vascular smooth muscle cell growth. Arterioscler Thromb Vasc Biol 25: 2069-2074, 2005.
52. van Leyen K, Kim HY, Lee SR, Jin G, Arai K, Lo EH. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 37: 3014-3018, 2006.
53. van Rooijen N, van Kesteren-Hendrikx E. "In vivo" depletion of macrophages by liposome-mediated "suicide". Methods Enzymol 373: 3-16, 2003.
54. Wen Y, Gu J, Chakrabarti SK, Aylor K, Marshall JJ, Takahashi Y, Yoshimoto T, Nadler JL. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-a. Endocrinology 148: 1313-1322, 2007.
55. Yamamoto S. Mammalian lipoxygenases: molecular structures and func-tions. Biochim Biophys Acta 1128: 117-131, 1992.
56. Yuan H, Lanting L, Xu ZG, Li SL, Swiderski P, Putta S, Jonnalagadda M, Kato M, Natarajan R. Effect of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in mouse model of type 1 diabetes. Am J Physiol Renal Physiol 295: F605-F617, 2008.
57. Zhang DX, Gauthier KM, Chawengsub Y, Campbell WB. A Chinduced relaxations of rabbit small mesenteric arteries: role of arachidonic acid metabolites and K. Am J Physiol Heart Circ Physiol 293: H152-H159, 2007.
58. Zhao L, Cuff CA, Moss E, Wille U, Cyrus T, Klein EA, Pratico D, Rader DJ, Hunter CA, Pure E, Funk CD. Selective interleukine-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atheroschlerosis in a mouse model of familial hypercholesterolemia. J Biol Chem 277: 35350-35356, 2002.